证券记录 · 已归档季度
VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
478.12K持有股份
$23.29M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 -30.0% ·
净新建仓位 +9.1%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | — | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | — | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | — | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | — | — |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | — | 1.49M | $1.49M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (被动) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (被动) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Geode Capital Management ✦ (被动) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 24.76K | 新增 | $1.21M | 0.0% | New | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 14.60K | -37.6% | $711,312 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 9.05K | +56.2% | $441,111 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 5.69K | 新增 | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 5.69K | 新增 | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Millennium Management | $1.21M | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
已清仓
| Two Sigma Investments | $274,810 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 79 持有人, 40.44M 股份, $716.36M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据